Reduced mRNA expression of neuropeptide Y in the limbic system of tenascin gene disrupted mouse brain

Neuropeptides

Volumn 32, Issue 3, 1998, Pages 265-268

  Fukamauchi, F ^a   Aihara, O ^b   Kusakabe, M ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; TENASCIN;

ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; GENE; GENE DISRUPTION; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; MOUSE; NERVE FIBER GROWTH; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031833473     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90046-4     Document Type: Article

References (16)

1. Heilig M, Widerlov E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol 1995; 9: 115-136.
2. Kunovac J L, Stahl S M. Future directions in anxiolytic pharmacology. Psychiatr Clin North Am 1995; 18: 895-909.
3. Wettstein J G, Earley B, Junien J L. Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 1995; 65: 397-414.
4. Grundemar L, Hakanson R. Neuropeptide Y effector systems: perspectives for drug development. Trends Pharmacol Sci 1994; 15: 153-159.
5. Gehlert D R. Subtypes of receptors for neuropeptide Y: implications for the targeting of therapeutics. Life Sci 1994; 55: 551-562.
6. White J D. Neuropeptide Y: a central regulator of energy homeostasis. Regul Pept 1993; 49: 93-107.
7. Weinberg D H, Sirinathsinghji D J, Tan C P et al. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 1996; 271: 16435-16438.
8. Heilig M, Koob G F, Ekman R, Britton K T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 1994; 17: 80-85.
9. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992; 6: 1821-1831.
10. Fukamauchi F, Mataga N, Wang YJ, Sato S, Yoshiki A, Kusakabe M. Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Biochem Biophys Res Commun 1996; 221: 151-156.
11. Erickson H P. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5: 869-876.
12. Steindler D A, Settles D, Erickson H P et al. Tenascin knockout mice: barrels, boundary molecules, and glial scars. J Neurosci 1995; 15: 1971-1983.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
14. Zachrisson O, Mathe A A, Stenfors C, Lindefors N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neurosci Lett 1995; 194: 89-92.
15. Wahlestedt C, Pich E M, Koob G F, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense of oligodeoxynucleotides. Science 1993; 259: 528-531.
16. Bendotti C, Tarizzo G, Fumagalli F, Baldessari S, Samanin R. Increased expression of preproneuropeptide Y and preprosomatostatin mRNA in striatum after selective serotoninergic lesions in rats. Neurosci Lett 1993; 160: 197-200.